ABUS vs PTON · P/E 5.4, rev $6.2M vs P/E 92, rev $2.49B
Arbutus Biopharma Corp (ABUS) versus Peloton Interactive Inc (PTON) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Peloton Interactive Inc (PTON) is a leisure company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PTON revenue for 2025-06-30 was $2.49B. Net income was -$118.9M. Revenue was down 7.8% from 2024-06-30 to 2025-06-30. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
Not investment advice. Open the ABUS and PTON stock pages for the full models.
Not investment advice.